ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILT..............................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0755251A119970129EP95914346.01995041019961003enenen1994000723519940412GB1997012919970519970129199705

A61K 31/ 34 A I

A61K 31/ 341 A I

A61P 1/ 04 A I

C07D 307/ 52 A I

enLOW DOSAGE RANITIDINE COMPOSITIONS FOR THE TREATMENT OF MINOR GASTROINTESTINAL DISORDERS ASSOCIATED WITH EXCESS ACID SECRETIONfrCOMPOSITIONS FAIBLEMENT DOSEES EN RANITIDINE DESTINEES AU TRAITEMENT DE TROUBLES GASTRO-INTESTINAUX MINEURS LIES A UN EXCES DE SECRETION ACIDEdeWIEDRIGDOSIERTE RANITIDINZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON LEICHTEN GASTROINTESTINALEN BESCHWERDEN, DIE MIT ERHÖHTER SÄURESEKRETION VERBUNDEN SINDGLAXO GROUP LIMITEDGlaxo House, Berkeley AvenueGreenford, Middlesex UB6 0NNGBBYE, Alan Glaxo Research and Development LimitedGreenford RoadGreenford Middlesex UB6 0HEGBEVANS, Jill Glaxo Research and Development LimitedPark RoadWare Hertfordshire SG12 0DPGBHUCKLE, Derrick, PaulGlaxo Research and Development Limited Park RoadWare Hertfordshire SG12 0DPGBLACEY, Laurence, F.Glaxo Research and DevelopmentLtd. Greenford RoadGreenford, Middlesex UB6 0HE UGBRUE, John, PeterGlaxo Research and Development Limited Park RoadWare Hertfordshire SG12 0DPGBVolckman, Janis Florence, et alGlaxo Wellcome plc Glaxo Wellcome House, Berkeley AvenueGreenford, Middlesex UB6 0NNGBATBECHDEDKESFRGBGRIEITLILUMCNLPTSELT19961003SI19961003EP199500127119950410enWO199502748619951019199545